A5026482887- Multiple Sclerosis Research Studies
- Lipoproteins and Cardiovascular Health
- Blood Pressure and Hypertension Studies
- Metabolism, Diabetes, and Cancer
- Polyomavirus and related diseases
- Health Systems, Economic Evaluations, Quality of Life
- Peripheral Neuropathies and Disorders
- Neurological Disorders and Treatments
- Fungal Plant Pathogen Control
- Cytokine Signaling Pathways and Interactions
Servier (France)
2022
This article provides an overview of data on the role hypertension and dyslipidemia as leading factors determining clinical course athero sclerotic diseases. The need for a multifactorial approach to treatment patients with multiple risk progression such diseases is noted. describes results large-scale international studies confirming benefits combined antihypertensive lipid-lowering therapy. From point view current guidelines available evidence base, potential improving adherence using...
Teriflunomide is a novel oral medication for relapsing remitting multiple sclerosis (RRMS), which has demonstrated it's efficacy in relapse rate reduction. It's been confirmed by MRI results as well. It safe and well-tolerated, with mild transitory side effects. Nevertheless, risk management plan should be applied to minimize monitor possible adverse events. Терифлуномид - новый пероральный препарат для лечения рецидивирующе-ремиттирующей формы рассеянного склероза, продемонстрировавший свою...
Aim. To assess expedience of metformin combination with long-acting insulin, determine optimal doses for patients type 2 diabetesmellitus (DM2), and accomplish pharmacoeconomic analysis clinical efficiency various therapeutic modalities. Materials methods. Patients decompensated DM2 (n=126) were under observation 1 year during which they received rational hypoglycemictherapy insulin (LAI) at bedtime, the dose being titrated until desired level glycemic control wasachieved. The randomly...